# Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)

> **NCT02124759** · PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 20 (actual)

## Conditions studied

- Insulin Sensitivity

## Interventions

- **DRUG:** Sevelamer
- **DRUG:** Synbiotic
- **DRUG:** Maltodextrin
- **OTHER:** High Fat diet
- **OTHER:** Low Fat diet

## Key facts

- **NCT ID:** NCT02124759
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-02
- **Primary completion:** 2018-02-23
- **Final completion:** 2020-03-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02124759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02124759, "Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02124759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*